Report in English with a Dutch summary (KCE reports 45A)
Report in English with a Dutch summary (KCE reports 45A) Report in English with a Dutch summary (KCE reports 45A)
182 Screening for Colorectal Cancer: Appendices KCE reports vol.45 Nr. Title Issued by Year Familial Adenomatous Polyposis (FAP) & related 8 Colorectal cancer screening and surveillance: clinical guidelines and rationale - update based on new evidence 55. U.S. Multisociety Task Force on Colorectal Cancer (AGA/ASGE/ACP/ACG) 2003 People who have a genetic diagnosis of FAP, or are at risk of having FAP but genetic testing has not been performed or is not feasible, should have annual sigmoidoscopy, beginning at age 10-12 years, to determine if they are expressing the genetic abnormality. Genetic testing should be considered in patients with FAP who have relatives at risk. Genetic counseling should guide genetic testing and considerations of colectomy. Hereditary Non-Polyposis Colon Cancer (HNPCC) People with a genetic or clinical diagnosis of HNPCC or who are at increased risk for HNPCC should have colonoscopy every 1-2 years beginning at age 20-25 years, or 10 years earlier than the youngest age of colon cancer diagnosis in the family, whichever comes first. Genetic testing for HNPCC should be offered to firstdegree relatives of persons with a known inherited mismatch repair (MMR) gene mutation. It should also be offered when the family mutation is not already known, but 1 of the first 3 of the modified Bethesda Criteria is met. Personal history of CRC resection Patients with a colon cancer that has been resected with curative intent should have a colonoscopy around the time of initial diagnosis to rule out synchronous neoplasms. If the colon is obstructed preoperatively, colonoscopy can be performed approximately 6 months after surgery. If this or a complete preoperative examination is normal, subsequent colonoscopy should be offered after 3 years, and then, if normal, every 5 years. Personal history of colonpolyps Patients who have had 1 or more adenomatous polyps removed at colonoscopy should be managed according to the findings on that colonoscopy. Patients who have had numerous adenomas, a malignant adenoma (with invasive cancer), a large sessile adenoma, or an incomplete colonoscopy should have a short interval follow-up colonoscopy based on clinical judgment. Patients who have advanced or multiple adenomas (> 3) should have their first follow-up colonoscopy in 3 years. Patients who have 1 or 2 small (< 1 cm) tubular adenomas should have their first follow-up colonoscopy at 5 years. Future evidence may clarify the intervals more precisely. The timing of the subsequent colonoscopy should depend on the pathology and number of adenomas detected at follow-up colonoscopy. For example, if the first followup colonoscopy is normal or only 1 or 2 small (< 1 cm) tubular adenomas are found, the next colonoscopy can be in 5 years. Inflammatory bowel disease (IBD) In patients with long-standing, extensive inflammatory bowel disease, surveillance colonoscopy with systematic biopsies should be considered. This applies to both ulcerative colitis and Crohn´s colitis because the cancer risk is similar in both diseases. Miscellaneous Not included
KCE reports vol.45 Screening for Colorectal Cancer: Appendices 183 Nr. Title Issued by Year Familial Adenomatous Polyposis (FAP) & related 9 Management of Colorectal Cancer - A national clinical guideline 49. 10 Guidelines for colorectal cancer screening in high risk groups 190. Scottisch Intercollegiate Guidelines Network (SIGN) British Society of Gastroenterology (BSG) Association of Coloproctology for Great Britain and Ireland (ACPGBI) 2003 1. Genetic testing for APC gene mutation analysis 2. Yearly FS beginning at puberty 3. Colonoscopy every 2 to 3 years. Recommendation grade C 2002 1. FAP and variants: genetic testing + FS + OGD at puberty, repeat FS yearly 2. Juvenile polyposis and Peutz-Jegher: genetic testing + colonoscopy + OGD at puberty, repeat FS yearly Hereditary Non- Polyposis Colon Cancer (HNPCC) Gene carriers (HNPCC genes) and untested primary relatives of gene carriers: § Colonoscopy at first consulation or or 5 y younger then the youngest affected relative § Discuss gynaecological screening for endometrial or ovarian CA § Oesophagoduodeoscopy (OGD) for gastric CA screening § Consider screening for other cancers which may occur in specific families and are part of the HNPCC spectrum § Repeat colonoscopy & OGD every 2 y from 30- 70 y. Recommendation grade C At risk HNPCC, or more than 2 FDR (refer to clinical geneticist) as well as documented MMR gene carriers: Colonoscopy +/- OGD at 25 y or five years before earliest CRC in family; gastroscopy at age 50 or five yrs before earliest gastric cancer in family; repeat colonoscopy and gastroscopy two yearly Personal history of CRC resection Patients who have undergone curative CRC resection should be offered formal follow-up in order to facilitate detection of metastatic disease. Colonoscopic surveillance should be carried out as for adenomatous polyps Where the clinician suspects intraluminal recurrence, prompt colonoscopy is indicated. Recommendation grade A 1. Colonoscopy within 6 months of resection only if colon evaluation pre-op incomplete 2. Liver scan within two years post-op 3. Colonoscopy five yearly until 70 y Personal history of colonpolyps Inflammatory bowel disease (IBD) 1. 2 adenomas < 1 cm: surveillance colonoscopy at 5 years; if normal cease surveillance 2. 3 adenomas or at least one 1 cm or at least one showing severe dysplasia: surveillance colonoscopy at 3 years; if subsequently normal on two consecutive cases, cease surveillance 3. in case of uncertainty about complete removal of adenoma(s): follow-up colonoscopy 1 y 4. Colonoscopic surveillance should continue until age and fitness of the patient dictate that it should cease (consensus patient & doctor!) Recommendation grade D 1. Low risk: 1-2 adenomas, both < 1 cm: colonoscopy - no surveillance or five years-cease follow up after negative colonoscopy 2. Intermediate risk: 3-4 adenomas OR at least one adenoma > 1 cm: colonoscopy every 3 years until two consecutive negative colonoscopies, then no further surveillance 3. High risk: > 5 adenomas or > 3 with at least one > 1 cm: annual colonoscopy until out of this risk group then interval colonoscopy as per Intermediate risk group 4. Large sessile adenomas removed piecemeal: colonoscopy or FS (depending on polyp location) 3 monthly until no residual polyp; consider surgery 1. Patients with left-sided colitis or pancolitis of 10 years duration should undergo 3 yearly colonoscopy with mucosal biopsies and biopsy of any suspected lesion. 2. The frequency of colonoscopy should increase to yearly when the disease has been present for 20 years or when indeterminate dysplasia has been diagnosed. Recommendation grade D 1. Ulcerative colitis and Crohn s colitis: colonoscopy + biopsies every 10 cm, starting for pancolitis eight years and for leftsided colitis 15 years from onset of symptoms; repeat 3 yearly in second decade, 2 yearly in third decade, subsequently annually 2. IBD + primary sclerosing cholangitis (pSC) +/- orthoptic liver transplant (OLT): colonoscopy with biopsy every 10 cm at diagnosis of PSC; repeat yearly Miscellaneous Not included 1. Ureterosigmoidostomy: FS 10 yrs after surgery; repeat annually 2. Acromegaly: colonoscopy at 40 years; repaet 5 yearly
- Page 142 and 143: 132 Screening for Colorectal Cancer
- Page 144 and 145: 134 Screening for Colorectal Cancer
- Page 146 and 147: 136 Screening for Colorectal Cancer
- Page 148 and 149: 138 Screening for Colorectal Cancer
- Page 150 and 151: 140 Screening for Colorectal Cancer
- Page 152 and 153: 142 Screening for Colorectal Cancer
- Page 154 and 155: 144 Screening for Colorectal Cancer
- Page 156 and 157: 146 Screening for Colorectal Cancer
- Page 158 and 159: 148 Screening for Colorectal Cancer
- Page 160 and 161: 150 Screening for Colorectal Cancer
- Page 162 and 163: 152 Screening for Colorectal Cancer
- Page 164 and 165: 154 Screening for Colorectal Cancer
- Page 166 and 167: 156 Screening for Colorectal Cancer
- Page 168 and 169: 158 Screening for Colorectal Cancer
- Page 170 and 171: 160 Screening for Colorectal Cancer
- Page 172 and 173: 162 Screening for Colorectal Cancer
- Page 174 and 175: 164 Screening for Colorectal Cancer
- Page 176 and 177: 166 Screening for Colorectal Cancer
- Page 178 and 179: 168 Screening for Colorectal Cancer
- Page 180 and 181: 170 Screening for Colorectal Cancer
- Page 182 and 183: 172 Screening for Colorectal Cancer
- Page 184 and 185: 174 Screening for Colorectal Cancer
- Page 186 and 187: 176 Screening for Colorectal Cancer
- Page 188 and 189: 178 Screening for Colorectal Cancer
- Page 190 and 191: 180 Screening for Colorectal Cancer
- Page 194 and 195: 184 Screening for Colorectal Cancer
- Page 196 and 197: 186 Screening for Colorectal Cancer
- Page 198 and 199: 188 Screening for Colorectal Cancer
- Page 200 and 201: 190 Screening for Colorectal Cancer
- Page 202 and 203: 192 Screening for Colorectal Cancer
- Page 204 and 205: 194 Screening for Colorectal Cancer
- Page 206 and 207: 196 Screening for Colorectal Cancer
- Page 208 and 209: 198 Screening for Colorectal Cancer
- Page 210 and 211: 200 Screening for Colorectal Cancer
- Page 212 and 213: 202 Screening for Colorectal Cancer
- Page 214 and 215: 204 Screening for Colorectal Cancer
- Page 216 and 217: 206 Screening for Colorectal Cancer
- Page 218 and 219: 208 Screening for Colorectal Cancer
- Page 220 and 221: 210 Screening for Colorectal Cancer
- Page 222 and 223: 212 Screening for Colorectal Cancer
- Page 224 and 225: 214 Screening for Colorectal Cancer
- Page 226 and 227: 216 Screening for Colorectal Cancer
- Page 228 and 229: 218 Screening for Colorectal Cancer
- Page 230 and 231: 220 Screening for Colorectal Cancer
- Page 232 and 233: 222 Screening for Colorectal Cancer
- Page 234 and 235: 224 Screening for Colorectal Cancer
- Page 236 and 237: 226 Screening for Colorectal Cancer
- Page 238 and 239: 228 Screening for Colorectal Cancer
- Page 240 and 241: 230 Screening for Colorectal Cancer
182 Screen<strong>in</strong>g for Colorectal Cancer: Appendices <strong>KCE</strong> <strong>reports</strong> vol.45<br />
Nr. Title Issued by Year Familial Adenomatous Polyposis<br />
(FAP) & related<br />
8 Colorectal cancer<br />
screen<strong>in</strong>g and<br />
surveillance: cl<strong>in</strong>ical<br />
guidel<strong>in</strong>es and rationale -<br />
update based on new<br />
evidence 55.<br />
U.S. Multisociety Task<br />
Force on Colorectal<br />
Cancer<br />
(AGA/ASGE/ACP/ACG)<br />
2003 People who have a genetic<br />
diagnosis of FAP, or are at risk of<br />
hav<strong>in</strong>g FAP but genetic test<strong>in</strong>g has<br />
not been performed or is not<br />
feasible, should have annual<br />
sigmoidoscopy, beg<strong>in</strong>n<strong>in</strong>g at age<br />
10-12 years, to determ<strong>in</strong>e if they<br />
are express<strong>in</strong>g the genetic<br />
abnormality. Genetic test<strong>in</strong>g<br />
should be considered <strong>in</strong> patients<br />
<strong>with</strong> FAP who have relatives at<br />
risk. Genetic counsel<strong>in</strong>g should<br />
guide genetic test<strong>in</strong>g and<br />
considerations of colectomy.<br />
Hereditary Non-Polyposis<br />
Colon Cancer (HNPCC)<br />
People <strong>with</strong> a genetic or<br />
cl<strong>in</strong>ical diagnosis of HNPCC<br />
or who are at <strong>in</strong>creased risk<br />
for HNPCC should have<br />
colonoscopy every 1-2 years<br />
beg<strong>in</strong>n<strong>in</strong>g at age 20-25 years,<br />
or 10 years earlier than the<br />
youngest age of colon cancer<br />
diagnosis <strong>in</strong> the family,<br />
whichever comes first.<br />
Genetic test<strong>in</strong>g for HNPCC<br />
should be offered to firstdegree<br />
relatives of persons<br />
<strong>with</strong> a known <strong>in</strong>herited<br />
mismatch repair (MMR) gene<br />
mutation. It should also be<br />
offered when the family<br />
mutation is not already<br />
known, but 1 of the first 3 of<br />
the modified Bethesda<br />
Criteria is met.<br />
Personal history of<br />
CRC resection<br />
Patients <strong>with</strong> a colon<br />
cancer that has been<br />
resected <strong>with</strong> curative<br />
<strong>in</strong>tent should have a<br />
colonoscopy around<br />
the time of <strong>in</strong>itial<br />
diagnosis to rule out<br />
synchronous<br />
neoplasms. If the<br />
colon is obstructed<br />
preoperatively,<br />
colonoscopy can be<br />
performed<br />
approximately 6<br />
months after surgery.<br />
If this or a complete<br />
preoperative<br />
exam<strong>in</strong>ation is normal,<br />
subsequent<br />
colonoscopy should<br />
be offered after 3<br />
years, and then, if<br />
normal, every 5 years.<br />
Personal history of<br />
colonpolyps<br />
Patients who have had 1 or<br />
more adenomatous polyps<br />
removed at colonoscopy<br />
should be managed<br />
accord<strong>in</strong>g to the f<strong>in</strong>d<strong>in</strong>gs on<br />
that colonoscopy.<br />
Patients who have had<br />
numerous adenomas, a<br />
malignant adenoma (<strong>with</strong><br />
<strong>in</strong>vasive cancer), a large<br />
sessile adenoma, or an<br />
<strong>in</strong>complete colonoscopy<br />
should have a short <strong>in</strong>terval<br />
follow-up colonoscopy<br />
based on cl<strong>in</strong>ical judgment.<br />
Patients who have advanced<br />
or multiple adenomas (> 3)<br />
should have their first<br />
follow-up colonoscopy <strong>in</strong> 3<br />
years.<br />
Patients who have 1 or 2<br />
small (< 1 cm) tubular<br />
adenomas should have their<br />
first follow-up colonoscopy<br />
at 5 years. Future evidence<br />
may clarify the <strong>in</strong>tervals<br />
more precisely.<br />
The tim<strong>in</strong>g of the<br />
subsequent colonoscopy<br />
should depend on the<br />
pathology and number of<br />
adenomas detected at<br />
follow-up colonoscopy. For<br />
example, if the first followup<br />
colonoscopy is normal<br />
or only 1 or 2 small (< 1<br />
cm) tubular adenomas are<br />
found, the next<br />
colonoscopy can be <strong>in</strong> 5<br />
years.<br />
Inflammatory bowel disease<br />
(IBD)<br />
In patients <strong>with</strong> long-stand<strong>in</strong>g,<br />
extensive <strong>in</strong>flammatory bowel<br />
disease, surveillance colonoscopy<br />
<strong>with</strong> systematic biopsies should<br />
be considered. This applies to<br />
both ulcerative colitis and<br />
Crohn´s colitis because the<br />
cancer risk is similar <strong>in</strong> both<br />
diseases.<br />
Miscellaneous<br />
Not <strong>in</strong>cluded